Correlations between chronic HCV infection and bone mass density after treatment with IFN-alpha
What is it about?
To compare the bone mass density in chronic hepatitis patients before and after interferon-α treatment.
Why is it important?
Due to the lack of published information about the effects of IFN-α treatment on quality of life in patients with chronic HCV in Iran, it was important to study the impact of IFN-α on quality of life in patients with chronic HCV and investigate the occurrence of clinical factors associated with IFN-α therapy that induces major depression in patients.
The following have contributed to this page: Dr Masoud Ghorbani and Dr Masoud Ghorbani